Literature DB >> 10735503

Mutational status of K-ras and TP53 genes in primary sarcomas of the heart.

J M Garcia1, R Gonzalez, J M Silva, G Dominguez, I S Vegazo, C Gamallo, M Provencio, P España, F Bonilla.   

Abstract

We investigated three patients with cardiac angiosarcomas and two with cardiac rhabdomyosarcomas, all for mutations at exons 5, 6, 7 and 8 of the p53 gene and at exon 1 of K-ras. No point mutations were observed in the p53 gene in any of the five cases; however, at exon 1 of K-ras, three patients (60%) presented the same mutation at the first base of codon 13 (G to A transition). Interestingly, this mutation was detected in both rhabdomyosarcoma and angiosarcoma histologic sarcoma types.

Entities:  

Mesh:

Year:  2000        PMID: 10735503      PMCID: PMC2363343          DOI: 10.1054/bjoc.1999.1060

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  15 in total

1.  Primary cardiac tumors: experience at the University of Minnesota.

Authors:  J E Molina; J E Edwards; H B Ward
Journal:  Thorac Cardiovasc Surg       Date:  1990-08       Impact factor: 1.827

2.  Primary cardiac sarcomas.

Authors:  J B Putnam; M S Sweeney; R Colon; L A Lanza; O H Frazier; D A Cooley
Journal:  Ann Thorac Surg       Date:  1991-06       Impact factor: 4.330

Review 3.  PCR-SSCP: a simple and sensitive method for detection of mutations in the genomic DNA.

Authors:  K Hayashi
Journal:  PCR Methods Appl       Date:  1991-08

4.  Primary sarcomas of the heart.

Authors:  A P Burke; D Cowan; R Virmani
Journal:  Cancer       Date:  1992-01-15       Impact factor: 6.860

5.  Frequency and diversity of p53 mutations in childhood rhabdomyosarcoma.

Authors:  C A Felix; C C Kappel; T Mitsudomi; M M Nau; M Tsokos; G D Crouch; P D Nisen; N J Winick; L J Helman
Journal:  Cancer Res       Date:  1992-04-15       Impact factor: 12.701

6.  Mutation analysis of p53 gene in childhood malignant solid tumors.

Authors:  T Kusafuka; M Fukuzawa; T Oue; Y Komoto; A Yoneda; A Okada
Journal:  J Pediatr Surg       Date:  1997-08       Impact factor: 2.545

7.  Mechanisms of p53 loss in human sarcomas.

Authors:  L M Mulligan; G J Matlashewski; H J Scrable; W K Cavenee
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

8.  H-ras-1 point mutations in soft tissue sarcomas.

Authors:  W Wilke; M Maillet; R Robinson
Journal:  Mod Pathol       Date:  1993-03       Impact factor: 7.842

9.  Heart transplantation for cardiac angiosarcoma: should its indication be questioned?

Authors:  M G Crespo; L A Pulpón; G Pradas; S Serrano; J Segovia; I Vegazo; C Salas; P España; L Silva; R Burgos
Journal:  J Heart Lung Transplant       Date:  1993 May-Jun       Impact factor: 10.247

10.  Primary cardiac tumors.

Authors:  N A Silverman
Journal:  Ann Surg       Date:  1980-02       Impact factor: 12.969

View more
  6 in total

1.  Sprouty-2 overexpression in C2C12 cells confers myogenic differentiation properties in the presence of FGF2.

Authors:  Cristina de Alvaro; Natalia Martinez; Jose M Rojas; Margarita Lorenzo
Journal:  Mol Biol Cell       Date:  2005-07-06       Impact factor: 4.138

2.  Primary vascular tumors of bone: a spectrum of entities?

Authors:  Sofie L J Verbeke; Judith V M G Bovée
Journal:  Int J Clin Exp Pathol       Date:  2011-07-25

3.  KRAS mutation in papillary fibroelastoma: a true cardiac neoplasm?

Authors:  Maike Wittersheim; Carina Heydt; Fabian Hoffmann; Reinhard Büttner
Journal:  J Pathol Clin Res       Date:  2017-03-07

4.  Combined mTOR and MEK inhibition is an effective therapy in a novel mouse model for angiosarcoma.

Authors:  Michelle L Chadwick; Adam Lane; Dana Thomas; Amanda R Smith; Angela R White; Dominique Davidson; Yuxin Feng; Elisa Boscolo; Yi Zheng; Denise M Adams; Anita Gupta; André Veillette; Lionel M L Chow
Journal:  Oncotarget       Date:  2018-05-15

Review 5.  Modeling human endothelial cell transformation in vascular neoplasias.

Authors:  Victoria W Wen; Karen L MacKenzie
Journal:  Dis Model Mech       Date:  2013-09       Impact factor: 5.758

Review 6.  Genetic aberrations and molecular biology of cardiac sarcoma.

Authors:  Milena Urbini; Annalisa Astolfi; Valentina Indio; Margherita Nannini; Carmine Pizzi; Pasquale Paolisso; Giuseppe Tarantino; Maria Abbondanza Pantaleo; Maristella Saponara
Journal:  Ther Adv Med Oncol       Date:  2020-05-18       Impact factor: 8.168

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.